Intestinal trefoil factor induces decay-accelerating factor expression and enhances the protective activities against complement activation in intestinal epithelial cells

Journal of Immunology

Volumn 167, Issue 7, 2001, Pages 3887-3893

  Andoh, A ^a   Kinoshita, K ^a   Rosenberg, I ^a   Podolsky, D K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECAY ACCELERATING FACTOR; INTESTINAL TREFOIL FACTOR;

ARTICLE; COMPLEMENT ACTIVATION; DIGESTIVE SYSTEM INJURY; HOST RESISTANCE; HUMAN; HUMAN CELL; INTESTINE MUCOSA; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 0035478342     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.7.3887     Document Type: Article

References (42)

1. Cytokine modulation of intestinal epithelial cell restitution: Central role of transforming growth factor-β
2. Trefoil peptides promote epithelial restitution through a TGF-β independent pathway
3. The trefoil peptide family
4. The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor- and MAP kinase-dependent interregulation
5. Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract
6. Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion
7. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease
8. Temporal expression of trefoil peptides in the TGF-α knockout mouse after gastric ulceration
9. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor α mRNAs in rat stomach
10. Impaired defense of intestinal mucosa in mice jacking intestinal trefoil factor
11. Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats
12. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis
13. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal noctual hemoglobinuria
14. Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55)
15. Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo
16. Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract
17. Local secretion of complement C3 in the exocrine pancreas: Ductal epithelial cells are possible biosynthetic site
18. Characterization of complement C3, C4, and factor B molecules in human bile
19. Enhanced local production of complement components in the small intestines of patients with Crohn's disease
20. Detection of complement C3 and factor B gene expression in normal colorectal mucosa, adenoma and carcinoma
21. Differential cytokine regulation of complement C3, C4 and factor B synthesis in human intestinal epithelial cell line, Caco-2
22. Evidence for an acute phase response in human intestinal epithelial cells
23. Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis
24. Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis
25. Association of subepithelial deposition of activated complement and immunoglobulin G and M response to gluten in celiac disease
26. Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis
27. Increased expression of decay-accelerating factor (CD55) in the inflamed mucosa of patients with ulcerative colitis
28. Characterization of human and rat intestinal trefoil factor produced in yeast
29. Interleukin-4 acts as an inducer of decay accelerating factor gene expression in human intestinal epithelial cells
30. Identificatioon of 5′-flanking regions affecting the expression of the human decay accelerating factor gene and their role in tissue-specific expression
31. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
32. NF-κB: Pleiotropic mediator of inducible and tissue-specific gene control
33. Tumor necrosis factor-α up-regulates decay-accelerating factor gene expression in human intestinal epithelial cells
34. Differential cytokine expression by human intestinal epithelial cell lines: Regulated expression of interleukin-8
35. The complement system
36. Superinduction of interleukin-6 mRNA in lung epithelial H292 cells depends on transiently increased C/EBP activity and durable increased mRNA stability
37. Superinduction of cytokine gene transcription by ciprofloxacin
38. Biochemical studies on red cells from a patient with the lnab phenotype (decay-accelerating factor deficiency)
39. A possible null phenotype in the Cromer blood group complex
40. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement
41. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism
42. p38 Mitogen-activated protein kinase regulates cyclooxygenae-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes